Foshan Ionova Biotherapeutics Co., Inc.;Shenzhen Ionova Life Science Co., Ltd.
发明人:
ZHOU, Gang,SUN, Yongkui,WANG, Zhaoyin
申请号：
AU2019229130
公开号：
AU2019229130A1
申请日:
2019.03.04
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention provides pharmaceutically acceptable salts of compounds of Formula I that are potent EP4 receptor antagonists and can be used for treating cancer or inflammatory diseases alone or in combination with antibody therapy, radiation therapy, anti‐metabolite chemotherapy to a subject in need thereof.
